BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

Clinical trial NCT01669174 · COMPLETED

Trial details

NCT number: NCT01669174
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD) With Cachexia

Start date: 2012-09-01
Primary completion: 2014-12-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.